Ramsay Santé reports H1 EBITDA of EUR 284.8 million (+0.1%)

Reuters
Feb 26
Ramsay Santé reports H1 EBITDA of EUR 284.8 million (+0.1%)

Ramsay Santé reported H1 (six months) results ended Dec. 31, 2025, with revenue of EUR 2.6 billion, up 3.3% (like-for-like +2.3%). EBITDA was EUR 284.8 million, up 0.1%, with an 11.0% margin. Net result attributable to owners was a loss of EUR 34.9 million, improving by EUR 8.2 million year-on-year, while operating cash flow was EUR 122.6 million, down EUR 47.3 million. Net financial debt stood at EUR 3.8 billion, including EUR 1.8 billion of restated (pre-IFRS16) net debt, and pre-IFRS16 restated net leverage was 5.3x. The company said France revenue rose 1.9%, supported by higher admissions, including a 2.5% increase in MSO patient stays admissions, and around 350,000 emergency presentations during the half-year; it also cited the opening of three mental health day facilities and the installation of six new imaging equipment since July 2025. Nordic countries revenue increased 6.4%, including a EUR 26.4 million favourable foreign exchange impact, with like-for-like growth of 2.8%. Ramsay Santé noted a EUR 20 million shortfall from the end of the French government’s revenue guarantee from Jan. 1, 2025, and said cost-control and efficiency initiatives helped keep EBITDA stable despite tariff indexation lagging cost inflation. After the period, Capio began a new eight-year contract (extendable to 12 years) to operate St. Göran’s Hospital in Stockholm from Jan. 5, 2026, with a contract value calculated over 12 years of EUR 4.8 billion (SEK 55 billion) and improved pricing terms. Ramsay Santé also said it noted Ramsay Health Care Limited’s proposed plan to distribute its 52.79% stake in Ramsay Santé to its shareholders, with potential implementation during Q4 2026, subject to approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Générale de Santé SA published the original content used to generate this news brief on February 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10